PD-1/PD-L1 inhibitory peptide C8

The PD-1/PD-L1 inhibitory peptide C8 is a research tool that blocks the immune checkpoint interaction, resulting in T cell activation and enhanced IFN-γ production. It has shown antitumor efficacy in murine models, supporting its use in immuno-oncology research for both in vitro and in vivo applications.